These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7696679)

  • 21. Genetic heterogeneity of Usher syndrome type II.
    Pieke Dahl S; Kimberling WJ; Gorin MB; Weston MD; Furman JM; Pikus A; Möller C
    J Med Genet; 1993 Oct; 30(10):843-8. PubMed ID: 7901420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A syndrome with retinitis pigmentosa, progressive hearing impairment, vestibular dysfunction, and congenital cataract.
    Rosenberg T; Parving A
    Acta Ophthalmol Scand Suppl; 1996; (219):50-3. PubMed ID: 8741120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for a fourth locus in Usher syndrome type I.
    Gerber S; Larget-Piet D; Rozet JM; Bonneau D; Mathieu M; Der Kaloustian V; Munnich A; Kaplan J
    J Med Genet; 1996 Jan; 33(1):77-9. PubMed ID: 8825055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ciliopathy: Usher Syndrome.
    Tsang SH; Aycinena ARP; Sharma T
    Adv Exp Med Biol; 2018; 1085():167-170. PubMed ID: 30578505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic characterization of retinitis pigmentosa associated with deafness.
    Paredes ÁC; López G; Gelvez N; Tamayo ML
    Biomedica; 2022 May; 42(Sp. 1):130-143. PubMed ID: 35866736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on the genetics of usher syndrome.
    Millán JM; Aller E; Jaijo T; Blanco-Kelly F; Gimenez-Pardo A; Ayuso C
    J Ophthalmol; 2011; 2011():417217. PubMed ID: 21234346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel locus for Usher syndrome type I, USH1G, maps to chromosome 17q24-25.
    Mustapha M; Chouery E; Torchard-Pagnez D; Nouaille S; Khrais A; Sayegh FN; Mégarbané A; Loiselet J; Lathrop M; Petit C; Weil D
    Hum Genet; 2002 Apr; 110(4):348-50. PubMed ID: 11941484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic heterogeneity of Usher syndrome: analysis of 151 families with Usher type I.
    Astuto LM; Weston MD; Carney CA; Hoover DM; Cremers CW; Wagenaar M; Moller C; Smith RJ; Pieke-Dahl S; Greenberg J; Ramesar R; Jacobson SG; Ayuso C; Heckenlively JR; Tamayo M; Gorin MB; Reardon W; Kimberling WJ
    Am J Hum Genet; 2000 Dec; 67(6):1569-74. PubMed ID: 11060213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular genetic study of Usher syndrome in Spain].
    Jaijo T; Aller E; Beneyto M; Nájera C; Millán JM
    Acta Otorrinolaringol Esp; 2005; 56(7):285-9. PubMed ID: 16240916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hearing loss in Usher syndrome type II is nonprogressive.
    Reisser CF; Kimberling WJ; Otterstedde CR
    Ann Otol Rhinol Laryngol; 2002 Dec; 111(12 Pt 1):1108-11. PubMed ID: 12498372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linkage studies of Usher syndrome type 1: exclusion results from the Usher syndrome consortium.
    Keats BJ; Todorov AA; Atwood LD; Pelias MZ; Hejtmancik JF; Kimberling WJ; Leppert M; Lewis RA; Smith RJ
    Genomics; 1992 Nov; 14(3):707-14. PubMed ID: 1427898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The combination of vestibular impairment and congenital sensorineural hearing loss predisposes patients to ocular anomalies, including Usher syndrome.
    Kletke S; Batmanabane V; Dai T; Vincent A; Li S; Gordon KA; Papsin BC; Cushing SL; Héon E
    Clin Genet; 2017 Jul; 92(1):26-33. PubMed ID: 27743452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Usher syndrome type 2A: clinical findings in obligate carriers.
    van Aarem A; Cremers CW; Pinckers AJ; Huygen PL; Hombergen GC; Kimberling BJ
    Int J Pediatr Otorhinolaryngol; 1995 Mar; 31(2-3):159-74. PubMed ID: 7782174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing.
    Oishi M; Oishi A; Gotoh N; Ogino K; Higasa K; Iida K; Makiyama Y; Morooka S; Matsuda F; Yoshimura N
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7369-75. PubMed ID: 25324289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usher syndrome in the city of Birmingham--prevalence and clinical classification.
    Hope CI; Bundey S; Proops D; Fielder AR
    Br J Ophthalmol; 1997 Jan; 81(1):46-53. PubMed ID: 9135408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usher syndrome clinical types I and II: could ocular symptoms and signs differentiate between the two types?
    Tsilou ET; Rubin BI; Caruso RC; Reed GF; Pikus A; Hejtmancik JF; Iwata F; Redman JB; Kaiser-Kupfer MI
    Acta Ophthalmol Scand; 2002 Apr; 80(2):196-201. PubMed ID: 11952489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic heterogeneity of Usher syndrome type II: localisation to chromosome 5q.
    Pieke-Dahl S; Möller CG; Kelley PM; Astuto LM; Cremers CW; Gorin MB; Kimberling WJ
    J Med Genet; 2000 Apr; 37(4):256-62. PubMed ID: 10745043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic homogeneity and phenotypic variability among Ashkenazi Jews with Usher syndrome type III.
    Ness SL; Ben-Yosef T; Bar-Lev A; Madeo AC; Brewer CC; Avraham KB; Kornreich R; Desnick RJ; Willner JP; Friedman TB; Griffith AJ
    J Med Genet; 2003 Oct; 40(10):767-72. PubMed ID: 14569126
    [No Abstract]   [Full Text] [Related]  

  • 39. [On information regarding the Usher syndrome, a speial form of recessive damage to the labyrinth (a contribution on audiometric diagnosis)].
    WAGEMANN W
    HNO; 1961 Mar; 9():151-3. PubMed ID: 13782438
    [No Abstract]   [Full Text] [Related]  

  • 40. Retinitis pigmentosa: genetic mapping in X-linked and autosomal forms of the disease.
    Humphries P; Farrar GJ; Kenna P; McWilliam P
    Clin Genet; 1990 Jul; 38(1):1-13. PubMed ID: 2201466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.